Vaccine partnerships and investment at World Vaccine Congress 2027
Mar 8–11, 2027 Washington, DC ~3k attendees Website
7 organizations at World Vaccine Congress 2027 present work in partnerships & investment: 4 vaccine and drug developers, 1 public-health or non-profit body, 1 academic body and 1 supplier or service provider. Between them they bring 11 presentations to the program. Most represented: Sanofi (4 on the program), Eli Lilly (3 on the program), Omniose (1 on the program). As of Oct 8, 2026.
Format
Top represented
Showing 1–7 of 7 organizations
| Organization | World Vaccine Congress 2027 Attendance |
|---|---|
Sanofi Paris, France | |
Global pharmaceutical company with a large vaccines business spanning influenza, pediatric, meningitis and mRNA programs. | Booth Exhibiting (no floor booth listed) Chair Wed Mar 10 09:00 Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. Talk Wed Mar 10 15:40 |
Eli Lilly Indianapolis, IN | |
Global pharmaceutical company whose medicines span diabetes, obesity, oncology, immunology and neuroscience, with antibody research against infectious diseases. | Talk Mon Mar 8 10:00 Antibodies for Infectious Diseases Workshop Research on antibody medicines that treat or prevent infectious diseases. Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. |
Biotech developing bacterial vaccines, including a Klebsiella vaccine. | Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. |
Vaxcyte San Carlos, CA | |
Develops broad-spectrum conjugate vaccines, led by a 31-valent pneumococcal vaccine candidate. | Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. |
DCVMN Nyon, Switzerland | |
Alliance of vaccine manufacturers in developing countries working to supply quality vaccines at affordable prices. | Talk Wed Mar 10 16:40 Beyond the IP Blueprint: Operationalizing Deep Know-How and End-to-End Technology Transfer How vaccine makers in developing countries absorb technology transfers through trained workforces and plant-floor training, not only licensed patents and documents. |
Public health school of Harvard University, researching infectious disease, vaccines and health policy. | Panel Wed Mar 10 10:10 Fireside Chat: How to execute cross-sector partnerships & overcome market bottlenecks How investors and companies co-invest in vaccines beyond infectious disease, bridge early funding gaps and use blended public and private finance. |
Advanced Technology International Summerville, SC | |
Builds and manages government research consortia, such as the Medical CBRN Defense Consortium, that link U.S. agencies with industry and academia. | Booth Exhibiting at Booth 407 |
Instantly find 20 buyers in partnerships & investment
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World Vaccine Congress 2027 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction